Kynam Capital Management, LP 13D and 13G filings for Burning Rock Biotech Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 12:29 pm Purchase |
2024-09-30 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 989,217 12.020% |
119,774![]() (+13.78%) |
Filing |
2024-02-14 12:45 pm Unchanged |
2023-12-31 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 869,443 10.190% |
0 (Unchanged) |
Filing |
2024-01-10 4:08 pm Purchase |
2023-12-31 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 869,443 10.190% |
130,285![]() (+17.63%) |
Filing |
2023-02-10 1:16 pm Purchase |
2022-12-30 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 739,158 8.400% |
739,158![]() (New Position) |
Filing |